分化型甲状腺癌风险分层的新见解。
New insights in risk stratification of differentiated thyroid cancer.
机构信息
aDivision of Metabolism, Endocrinology and Diabetes bDivision of Metabolism, Endocrinology and Diabetes, and Hematology/Oncology, Department of Medicine, Ann Arbor, Michigan, USA.
出版信息
Curr Opin Oncol. 2014 Jan;26(1):1-7. doi: 10.1097/CCO.0000000000000022.
Abstract
PURPOSE OF REVIEW
Numerous staging and scoring systems exist for differentiated thyroid cancer (DTC), but all harbor limitations. This has prompted investigation for new factors with prognostic implications for DTC.
RECENT FINDINGS
Several new factors that may be involved in DTC risk stratification have emerged, such as thyroid stimulating hormone and molecular markers. In addition, others are controversial and being challenged, such as age, sex and lymph node involvement.
SUMMARY
The purpose of this review is to present recent updates in the literature on new potential risk stratification predictors for DTC.
摘要
目的综述
分化型甲状腺癌（DTC）有许多分期和评分系统，但都存在局限性。这促使人们研究新的因素，以寻找对 DTC 具有预后意义的因素。
最近的发现
已经出现了一些可能涉及 DTC 风险分层的新因素，例如促甲状腺激素和分子标志物。此外，还有一些因素存在争议并受到质疑，如年龄、性别和淋巴结受累。
总结
本文旨在介绍 DTC 新的潜在风险分层预测因子的最新文献更新。
相似文献
1
New insights in risk stratification of differentiated thyroid cancer.
Curr Opin Oncol. 2014 Jan;26(1):1-7. doi: 10.1097/CCO.0000000000000022.
2
Prognostic Factors in Differentiated Thyroid Cancer Revisited.
Isr Med Assoc J. 2017 Feb;19(2):114-118.
3
Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Bull Cancer. 2016 Jun;103(6):535-40. doi: 10.1016/j.bulcan.2016.04.003. Epub 2016 May 25.
4
The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
World J Surg. 2018 Jun;42(6):1762-1771. doi: 10.1007/s00268-017-4343-6.
5
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
6
The impact of age on thyroid cancer staging.
Curr Opin Endocrinol Diabetes Obes. 2018 Oct;25(5):330-334. doi: 10.1097/MED.0000000000000430.
7
NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Clin Biochem. 2017 Aug;50(12):696-702. doi: 10.1016/j.clinbiochem.2017.02.020. Epub 2017 Feb 27.
8
Survival and death causes in differentiated thyroid carcinoma.
J Clin Endocrinol Metab. 2006 Jan;91(1):313-9. doi: 10.1210/jc.2005-1322. Epub 2005 Nov 1.
9
Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
Thyroid. 2016 Oct;26(10):1480-1487. doi: 10.1089/thy.2016.0302. Epub 2016 Sep 22.
10
Risk and prognostic factors for differentiated thyroid cancer.
Hell J Nucl Med. 2006 Sep-Dec;9(3):156-62.
引用本文的文献
1
Multi-Omics and Management of Follicular Carcinoma of the Thyroid.
Biomedicines. 2023 Apr 19;11(4):1217. doi: 10.3390/biomedicines11041217.
2
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
Oncologist. 2021 Feb;26(2):e251-e260. doi: 10.1634/theoncologist.2020-0306. Epub 2020 Sep 16.
3
Impact of gender on survival in patients with laryngeal squamous cell carcinoma: a propensity score matching analysis.
Int J Clin Exp Pathol. 2020 Mar 1;13(3):573-581. eCollection 2020.
4
Microscopic extrathyroid extension in papillary thyroid carcinoma: impact on response to therapy.
Arch Endocrinol Metab. 2020 Apr;64(2):144-149. doi: 10.20945/2359-3997000000210. Epub 2020 Mar 27.
5
Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series.
Arch Endocrinol Metab. 2019 Mar-Apr;63(2):97-106. doi: 10.20945/2359-3997000000120. Epub 2019 Mar 21.
6
Papillary thyroid carcinoma: different clinical behavior among pT3 tumors.
Endocrine. 2016 Sep;53(3):754-60. doi: 10.1007/s12020-016-0927-4. Epub 2016 Mar 21.
7
Iodine-131 avid distant metastasis in differentiated thyroid cancer: An initial institutional experience from the northern part of India.
Indian J Nucl Med. 2015 Jul-Sep;30(3):227-32. doi: 10.4103/0972-3919.158530.
本文引用的文献
1
Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate.
Clin Interv Aging. 2013;8:871-7. doi: 10.2147/CIA.S44772. Epub 2013 Jul 10.
2
BRAF mutation in papillary thyroid carcinoma: predictive value for long-term prognosis and radioiodine sensitivity.
Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Feb;131(1):7-13. doi: 10.1016/j.anorl.2013.01.004. Epub 2013 Jul 9.
3
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.
Thyroid. 2013 Jun;23(6):683-94. doi: 10.1089/thy.2012.0307.
4
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
Thyroid. 2014 Jan;24(1):35-42. doi: 10.1089/thy.2013.0062. Epub 2013 Sep 4.
5
Progress in molecular-based management of differentiated thyroid cancer.
Lancet. 2013 Mar 23;381(9871):1058-69. doi: 10.1016/S0140-6736(13)60109-9. Epub 2013 Mar 22.
6
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
JAMA. 2013 Apr 10;309(14):1493-501. doi: 10.1001/jama.2013.3190.
7
RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
J Clin Endocrinol Metab. 2013 May;98(5):E914-22. doi: 10.1210/jc.2012-3396. Epub 2013 Mar 28.
8
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
Thyroid. 2013 Nov;23(11):1401-7. doi: 10.1089/thy.2013.0011. Epub 2013 Jul 25.
9
Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010.
Thyroid. 2013 Nov;23(11):1470-8. doi: 10.1089/thy.2012.0573. Epub 2013 Jun 14.
10
RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
Cancer. 2013 May 15;119(10):1792-9. doi: 10.1002/cncr.27893. Epub 2013 Feb 21.
Zotero 插件